Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Current Deferred Revenue (2017 - 2025)

Historic Current Deferred Revenue for cbdMD (YCBD) over the last 8 years, with Q3 2025 value amounting to $506289.0.

  • cbdMD's Current Deferred Revenue rose 60.31% to $506289.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $506289.0, marking a year-over-year increase of 60.31%. This contributed to the annual value of $506289.0 for FY2025, which is 60.31% up from last year.
  • Per cbdMD's latest filing, its Current Deferred Revenue stood at $506289.0 for Q3 2025, which was up 60.31% from $509198.0 recorded in Q2 2025.
  • In the past 5 years, cbdMD's Current Deferred Revenue ranged from a high of $557353.0 in Q1 2025 and a low of $755.0 during Q2 2021
  • Moreover, its 4-year median value for Current Deferred Revenue was $506289.0 (2025), whereas its average is $423116.4.
  • In the last 5 years, cbdMD's Current Deferred Revenue soared by 17166.79% in 2024 and then tumbled by 742.58% in 2025.
  • cbdMD's Current Deferred Revenue (Quarter) stood at $755.0 in 2021, then skyrocketed by 24435.89% to $185246.0 in 2023, then surged by 184.72% to $527438.0 in 2024, then dropped by 4.01% to $506289.0 in 2025.
  • Its Current Deferred Revenue stands at $506289.0 for Q3 2025, versus $509198.0 for Q2 2025 and $557353.0 for Q1 2025.